Predictors of renal function decline in patients with gastroenteropancreatic neuroendocrine tumors undergoing [177Lu]Lu-DOTA-TATE therapy by Felix L. Herr, Christian Dascalescu, Victoria Fusch, Caroline Smith, Ricarda Ebner, Mathias J. Zacherl, Florian Eckenweber, Konrad Klimek, Christoph J. Auernhammer, Christine Spitzweg, Jens Ricke, Maurice M. Heimer, Clemens C. Cyran, Rudolf A. Werner, Gabriel T. Sheikh

Get full text